Market accessOfficial

Estonia's human medicines market grows 11.7% in third quarter of 2026

🇪🇪 Ravimiamet · Mon 16 Nov 2026

Ravimiamet reports human medicines turnover of €154 million for Q3 2026, while the veterinary market rose 1.3% to €5.1 million year on year.

Estonia's human medicines market grew by 11.7% in the third quarter of 2026 compared with the same period of 2025, reaching €154 million, according to figures from the State Agency of Medicines (Ravimiamet). The veterinary medicines market grew 1.3%, to €5.1 million.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Official source: Ravimiamet ↗

Article written by VigiEye from the official source (Ravimiamet). AI-assisted; check the source before acting.